Inside the Lab Industry

COVID-19 Surge Lifts Overall Molecular Point of Care Testing Market to $900 Million

To the uninitiated, the term molecular point-of-care (POC) testing might sound like an oxymoron. After all, the science of molecular microbiology is all about detecting targeted bits of microbial … [Read more...]

Inside the Lab Industry

COVID-19 Drives Unprecedented but Ultimately Unsustainable Growth

As strange as it may sound, the COVID-19 pandemic has driven unprecedented revenue growth in the diagnostics industry. The fourth quarter of 2020 not only continued but accelerated the climb in … [Read more...]

DX Earnings Report

Q3 Creates the Perfect Storm of Sustained COVID-19 Tailwinds and Diminishing Headwinds

July through September 2020 was a remarkable quarter for most diagnostics firms. In fact, it was the closest thing to a perfect storm for earnings. Pandemic tailwinds drove massive revenues for firms … [Read more...]

Economic Trends

Labs Lost Less & Will Recover More than Other Healthcare Sectors, Says New Report

Although it’s not exactly “Happy Days Are Here Again,” a new S&P report is predicting that the healthcare sector has seen the worst of the COVID-19 pandemic and won’t have to go through “a return … [Read more...]

DX Earnings Report

Q2 Revenues Slide but By Less than Wall Street Expected

As expected, the COVID-19 pandemic took a tremendous bite out of lab company earnings in the second quarter. However, the losses were largely below expectations, significantly below in many cases. And … [Read more...]

Test Utilization

Supplies Shortages Continue to Bedevil COVID-19 Testing Efforts

What was true at the beginning of the public health emergency remains true today: laboratories simply cannot obtain the supplies they need to deliver desperately needed COVID-19 molecular testing in a … [Read more...]

DX Earnings Report

Strong Q1 Earnings Belie the True Financial Devastation of COVID-19

The bad news is that COVID-19 is very, very bad for business; the good news—sort  of—is that the pandemic had just the last few weeks of March to wreak havoc on 2020 Q1 earnings reports. And even that … [Read more...]

Market Trends

New Survey Documents Extent of Lab Business Damage Inflicted by COVID-19

The fact that the lab business is taking a beating as a result of the COVID-19 pandemic is hardly news. But a recent survey sheds important new light on the extent of the devastation. The Kalorama … [Read more...]

EARNINGS

DX Earnings Report: Lab Market Consolidates but Survivors Stay Strong

PAMA and private payor rate cuts and increased market competitiveness are fueling consolidation and driving smaller, independent labs (other than specialty labs) into near extinction. But the big, … [Read more...]

REVENUES

DX Earnings Report: Markets Soften, Payors Harden but Growth Continues

Lab business is getting tougher. While PAMA cuts are hurting Medicare revenues, pressure from private payors may be even more intense both at the pricing front end and claims denial back end. Economic … [Read more...]


(-00000g2)